DTB select: DOAC drug interactions and risk of major bleeding
Summary and context are provided for a UK case–control study which found that use of antiplatelet drugs and SSRIs with DOACs was associated with an increased risk of major bleeds requiring hospital admission.
Source:
Drug and Therapeutics Bulletin